1Abt. Zell- und Virusgenetik, Heinrich-Pette-Institut für Experimentelle Virologie und Immunologie, Hamburg, Germany.
Gene therapy using retroviral vectors shows great promise for treating inherited and acquired blood disorders by modifying hematopoietic stem cells (HSCs). Further research is needed to overcome current limitations in gene transfer efficiency and expression for successful HSC gene therapy.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: